Royalty Pharma to pay Ferring $300 million upfront and a potential $200 million milestone payment in exchange...
Ad hoc announcement pursuant to Art. 53 LR Royalty Pharma to pay Ferring $300 million upfront and a potential $200 million milestone payment in...
Net cash provided by operating activities (GAAP) of $608 million and Adjusted Cash Receipts(1) (non-GAAP) of...
NEW YORK, July 18, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will...
NEW YORK, July 17, 2023 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.